210 related articles for article (PubMed ID: 25741884)
1. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
Ploegstra MJ; Arjaans S; Zijlstra WMH; Douwes JM; Vissia-Kazemier TR; Roofthooft MTR; Hillege HL; Berger RMF
Chest; 2015 Sep; 148(3):655-666. PubMed ID: 25741884
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
[TBL] [Abstract][Full Text] [Related]
3. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry.
Beghetti M; Brand M; Berger RMF; Humpl T; Wheeler JG; Ivy DD; Bonnet D;
Int J Cardiol; 2019 Aug; 289():110-115. PubMed ID: 31072635
[TBL] [Abstract][Full Text] [Related]
4. Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.
Roofthooft MT; Douwes JM; Vrijlandt EJ; Berger RM
Am J Cardiol; 2013 Nov; 112(9):1505-9. PubMed ID: 23972345
[TBL] [Abstract][Full Text] [Related]
5. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.
Zijlstra WMH; Douwes JM; Rosenzweig EB; Schokker S; Krishnan U; Roofthooft MTR; Miller-Reed K; Hillege HL; Ivy DD; Berger RMF
J Am Coll Cardiol; 2014 May; 63(20):2159-2169. PubMed ID: 24681143
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Tremblay É; Gosselin C; Mai V; Lajoie AC; Kilo R; Weatherald J; Lacasse Y; Bonnet S; Lega JC; Provencher S
Circulation; 2022 Aug; 146(8):597-612. PubMed ID: 35862151
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
Farber HW; Miller DP; Meltzer LA; McGoon MD
J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
[TBL] [Abstract][Full Text] [Related]
9. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
[TBL] [Abstract][Full Text] [Related]
10. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
Studer SM; Gilkin RJ
Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
[TBL] [Abstract][Full Text] [Related]
13. Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.
Zijlstra WMH; Ploegstra MJ; Vissia-Kazemier T; Roofthooft MTR; Sarvaas GDM; Bartelds B; Rackowitz A; van den Heuvel F; Hillege HL; Plasqui G; Berger RMF
Am J Respir Crit Care Med; 2017 Jul; 196(2):220-227. PubMed ID: 28178426
[TBL] [Abstract][Full Text] [Related]
14. Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients.
Simonneau G; Galiè N; Jansa P; Meyer GM; Al-Hiti H; Kusic-Pajic A; Lemarié JC; Hoeper MM; Rubin LJ
Int J Cardiol; 2014 Mar; 172(2):332-9. PubMed ID: 24525158
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
16. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension.
Huang J; Mehta S; Mura M
Respiration; 2015; 89(5):365-73. PubMed ID: 25791910
[TBL] [Abstract][Full Text] [Related]
17. Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension.
Henkens IR; Van Wolferen SA; Gan CT; Boonstra A; Swenne CA; Twisk JW; Kamp O; van der Wall EE; Schalij MJ; Vonk-Noordegraaf A; Vliegen HW
Am J Cardiol; 2009 May; 103(10):1451-6. PubMed ID: 19427445
[TBL] [Abstract][Full Text] [Related]
18. Supraventricular Arrhythmias in Patients With Pulmonary Arterial Hypertension.
Cannillo M; Grosso Marra W; Gili S; D'Ascenzo F; Morello M; Mercante L; Mistretta E; Salera D; Zema D; Bissolino A; Fusaro E; Marra S; Libertucci D; Gaita F
Am J Cardiol; 2015 Dec; 116(12):1883-9. PubMed ID: 26522342
[TBL] [Abstract][Full Text] [Related]
19. Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension.
Douwes JM; Hegeman AK; van der Krieke MB; Roofthooft MT; Hillege HL; Berger RM
Int J Cardiol; 2016 Jan; 202():34-9. PubMed ID: 26386916
[TBL] [Abstract][Full Text] [Related]
20. [Sildenafil therapy for pulmonary hypertension: a prospective study].
Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zeng WJ; Zhu F; He JG
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):419-23. PubMed ID: 21781512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
